Revolutionizing Cancer Trial Matching: PCC and Massive Bio’s AI-driven Multi-sponsor Study Delivers Promising Results
The Precision Cancer Consortium (PCC), in partnership with Massive Bio, has unveiled compelling results from a comprehensive study conducted on a multi-sponsor pharmaceutical platform.
